Enhanced T-Cells Target Heart Inflammation
Our immune system’s T-cells hunt down invaders. Scientists improved this with CAR-T therapy, originally for cancer. In 2023, researchers adapted this approach to reduce heart inflammation in cancer patients with pacemakers. Their devices lasted longer as a result. Stanford’s ongoing research personalizes T-cell modifications based on individual immune profiles for even better outcomes. This technique reprograms the patient’s own immune cells to protect implanted devices rather than attack them.